Success of Cytoreductive TherapyVideo Categories: Polycythemia Vera
Supported through funding from Incyte
Dixie-Lee Esseltine, MD provides a brief overview of the dosing schedule and indications of ixazomib. She also reviews the phase 3 clinical trials of ixazomib that are currently ongoing.
Grant Lawless provides an overview of the value of personalized medicine in specialty medicines and primary care settings